- Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024
- Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device
- Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes
- Haemonetics Announces Proposed Convertible Senior Notes Offering
- Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website
More ▼
Key statistics
As of last trade Haemonetics Corp (HAE:NYQ) traded at 90.03, -8.10% below its 52-week high of 97.97, set on May 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 89.50 |
---|---|
High | 90.07 |
Low | 88.52 |
Bid | 89.97 |
Offer | 90.08 |
Previous close | 88.73 |
Average volume | 419.17k |
---|---|
Shares outstanding | 50.84m |
Free float | 50.36m |
P/E (TTM) | 39.51 |
Market cap | 4.60bn USD |
EPS (TTM) | 2.29 USD |
Data delayed at least 15 minutes, as of Jul 22 2024 20:12 BST.
More ▼